Department of Community Medicine, Dr. Baba Saheb Ambedkar Medical College and Hospital, Delhi, 110085, India.
Department of Development Studies, International Institute for Population Sciences (IIPS), Mumbai, 400088, India.
BMC Pulm Med. 2021 Nov 16;21(1):375. doi: 10.1186/s12890-021-01740-y.
Tuberculosis, as a communicable disease, is an ongoing global epidemic that accounts for high burden of global mortality and morbidity. Globally, with an estimated 10 million new cases and around 1.4 million deaths, TB has emerged as one of the top 10 causes of morbidity and mortality in 2019. Worst hit 8 countries account for two thirds of the new TB cases in 2019, with India leading the count. Despite India's engagement in various TB control activities since its first recognition through the resolution passed in the All-India Sanitary Conference in 1912 and launch of first National Tuberculosis Control Programme in 1962, it has remained a major public health challenge to overcome. To accelerate progress towards the goal of ending TB by 2025, 5 years ahead of the global SDG target, it is imperative to outline the incidence and mortality trends of tuberculosis in India. This study aims to provide deep insights into the recent trends of TB incidence and mortality in India from 1990 to 2019.
This is an observational study based on the most recent data from the Global Burden of Disease (GBD) Study 2019. We extracted numbers, age-specific and age-standardized incidence and mortality rates of Tuberculosis for the period 1990-2019 from the Global Health Data Exchange. The average annual percent change (AAPC) along with 95% Confidence Interval (CI) in incidence and mortality were derived by joinpoint regression analysis; the net age, period, and cohort effects on the incidence and mortality rates were estimated by using Age-Period-Cohort model.
During the study period, age-standardized incidence and mortality rates of TB in India declines from 390.22 to 223.01 and from 121.72 to 36.11 per 100,000 population respectively. The Joinpoint regression analysis showed a significant decreasing pattern in incidence rates in India between 1990 and 2019 for both male and female; but larger decline was observed in case of females (AAPC: - 2.21; 95% CI: - 2.29 to - 2.12; p < 0.001) as compared to males (AAPC: - 1.63; 95% CI: - 1.71 to - 1.54; p < 0.001). Similar pattern was observed for mortality where the declining trend was sharper for females (AAPC: - 4.35; 95% CI: - 5.12 to - 3.57; p < 0.001) as compared to males (AAPC: - 3.88; 95% CI: - 4.63 to - 3.11; p < 0.001). For age-specific rates, incidence and mortality rates of TB decreased for both male and female across all ages during this period. The age effect showed that both incidence and mortality significantly increased with advancing age; period effect showed that both incidence and mortality decreased with advancing time period; cohort effect on TB incidence and mortality also decreased from earlier birth cohorts to more recent birth cohorts.
Mortality and Incidence of TB decreased across all age groups for both male and female over the period 1990-2019. The incidence as well as mortality was higher among males as compared to females. The net age effect showed an unfavourable trend while the net period effect and cohort effect presented a favourable trend. Aging was likely to drive a continued increase in the mortality of TB. Though the incidence and mortality of tuberculosis significantly decreased from 1990 to 2019, the annual rate of reduction is not sufficient enough to achieve the aim of India's National Strategic plan 2017-2025. Approximately six decades since the launch of the National Tuberculosis Control Programme, TB still remains a major public health problem in India. Government needs to strengthen four strategic pillars "Detect-Treat-Prevent-Build" (DTPB) in order to achieve TB free India as envisaged in the National Tuberculosis Elimination Programme (2020).
结核病是一种传染病,是当前全球流行的一种疾病,导致全球发病率和死亡率居高不下。全球范围内,据估计有 1000 万新发病例和约 140 万人死亡,结核病已成为 2019 年发病率和死亡率最高的十大原因之一。受影响最严重的 8 个国家占 2019 年新发病例的三分之二,其中印度病例数最多。尽管印度自 1912 年全印度卫生会议通过决议并于 1962 年启动首个国家结核病控制规划以来,一直在开展各种结核病控制活动,但要克服这一主要公共卫生挑战仍任重道远。为了加速实现到 2025 年提前 5 年实现全球可持续发展目标的目标,必须概述印度结核病的发病率和死亡率趋势。本研究旨在深入了解印度从 1990 年到 2019 年结核病发病率和死亡率的最新趋势。
这是一项基于 2019 年全球疾病负担(GBD)研究的最新数据的观察性研究。我们从全球卫生数据交换中提取了 1990 年至 2019 年期间结核病的发病率和死亡率数据,包括特定年龄和标准化发病率和死亡率。使用 Joinpoint 回归分析得出发病率和死亡率的平均年变化百分比(AAPC)及其 95%置信区间(CI);使用年龄-时期-队列模型估计发病率和死亡率的净年龄、时期和队列效应。
在研究期间,印度标准化发病率和死亡率从 390.22 降至 223.01,从 121.72 降至 36.11/100000 人口。Joinpoint 回归分析显示,印度的发病率在 1990 年至 2019 年期间呈现出显著的下降趋势,男性和女性均如此;但女性的下降幅度更大(AAPC:-2.21;95%CI:-2.29 至-2.12;p<0.001),而男性的下降幅度较小(AAPC:-1.63;95%CI:-1.71 至-1.54;p<0.001)。死亡率也呈现出类似的趋势,女性的下降趋势更为陡峭(AAPC:-4.35;95%CI:-5.12 至-3.57;p<0.001),而男性的下降幅度较小(AAPC:-3.88;95%CI:-4.63 至-3.11;p<0.001)。在特定年龄组方面,发病率和死亡率在这一期间均呈下降趋势,男性和女性在所有年龄段都有所下降。年龄效应表明,发病率和死亡率随着年龄的增长而显著增加;时期效应表明,发病率和死亡率随着时间的推移而下降;发病率和死亡率的队列效应也从早期出生队列到最近出生队列逐渐降低。
1990 年至 2019 年间,男性和女性的所有年龄组的结核病死亡率和发病率均有所下降。与女性相比,男性的发病率和死亡率更高。净年龄效应显示出不利趋势,而净时期效应和队列效应呈现出有利趋势。随着人口老龄化,结核病的死亡率可能会继续增加。尽管结核病的发病率和死亡率从 1990 年到 2019 年显著下降,但每年的下降速度不足以实现印度 2017-2025 年国家战略计划的目标。自 1962 年启动国家结核病控制规划以来,大约 60 年来,结核病仍然是印度的一个主要公共卫生问题。政府需要加强“检测-治疗-预防-建设”(DTPB)四大战略支柱,以实现《国家结核病消除规划》(2020 年)中设想的无结核病印度。